Novo Nordisk A/S (NYSE: NVO) on Thursday submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for once-weekly CagriSema. The application covers CagriSema for use with ...

Detailed price information for Envue Medical Inc (FEED-Q) from The Globe and Mail including charting and trades.

As these systems evolve, I believe therapeutic ultrasound is poised to become medicine's next general-purpose platform.

Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug discovery platform. Built on seven years of development and ...

Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced a clinical ...

In the 1999 sci-fi classic The Matrix, “plugging in” symbolized digital enslavement. In 2025, for a paraplegia patient in ...

Leaked information reveals OpenAI is developing an AI pen with integrated ChatGPT; Google and its spectacular comeback in ...

Schrödinger, Inc. (Nasdaq: SDGR) provided an update on its progress across the business in 2025 and announced its strategic priorities for 2026. The company is continuing to focus on advancing its ...

Major stock indexes ended lower Tuesday, a day after the S&P 500 and Dow Jones Industrial Average set fresh records, as investors digested a consumer inflation reading that matched expectations and ...

Is the next great leap in human machine integration to come not from smartphones or AI chatbots, but from a coin-sized chip implanted in the brain? Elon Musk’s Neuralink is hurtling toward that vision ...

The FDA has accepted an investigational new drug application for an investigational and proprietary combination therapy to ...

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — A new program ...